Cargando…

Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study

Individual differences in required drug dosages exist based on the pharmacogenomic (PGx) profiles. This study aimed to assess associations between PGx profiles and adverse drug reactions (ADR) that lead to admissions to the emergency department (ED). ADR cases of the prospective multi-center observa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Just, Katja S., Dormann, Harald, Schurig, Marlen, Böhme, Miriam, Fracowiak, Jochen, Steffens, Michael, Scholl, Catharina, Seufferlein, Thomas, Gräff, Ingo, Schwab, Matthias, Stingl, Julia C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355597/ https://www.ncbi.nlm.nih.gov/pubmed/32527038 http://dx.doi.org/10.3390/jcm9061801

Ejemplares similares

CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study
por: Just, Katja S., et al.
Publicado: (2021)

Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study
por: Just, Katja S., et al.
Publicado: (2023)

The phenotype of adverse drug effects: Do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study
por: Just, Katja S., et al.
Publicado: (2020)

Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations
por: Bergs, Ingmar, et al.
Publicado: (2022)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes
por: Fracowiak, Jochen, et al.
Publicado: (2022)

Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?
por: Just, Katja S., et al.
Publicado: (2021)

Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts
por: Just, Katja S., et al.
Publicado: (2019)

Focus on pharmacogenomics, phytonutrient-drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
por: Ray, Sidhartha D., et al.
Publicado: (2021)

Focus on pharmacogenomics, phytonutrient–drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
por: Ray, Sidhartha D., et al.
Publicado: (2022)

Adverse Drug Reactions (ADR) in the inPatients of Medicine Department of a Rural Tertiary Care Teaching Hospital and Influence of Pharmacovigilance in Reporting ADR
por: Gor, A.P., et al.
Publicado: (2008)

Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
por: Hichert, Vivien, et al.
Publicado: (2017)

Network Characteristic Analysis of ADR-related Proteins and Identification of ADR-ADR Associations
por: Chen, Xiujie, et al.
Publicado: (2013)

Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions
por: Bergs, Ingmar, et al.
Publicado: (2022)

Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR
por: Huebner, Tatjana, et al.
Publicado: (2020)

Children and ADRs (Adverse Drug Reactions)
por: Napoleone, Ettore
Publicado: (2010)

Epidermiology of adverse drug reactions (ADRs) in the elderly
por: Ju-Young, Kim, et al.
Publicado: (2014)

Adverse Drug Reactions (ADRs) of Montelukast in Children
por: Al-Shamrani, Abdullah, et al.
Publicado: (2022)

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports
por: Leitzen, Sarah, et al.
Publicado: (2022)

Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity
por: Kemski, Sarah, et al.
Publicado: (2021)

Patterns of adverse drug reactions (ADRs) in Saudi Arabia
por: Bin Yousef, Nora, et al.
Publicado: (2022)

Population nutrikinetics of green tea extract
por: Scholl, Catharina, et al.
Publicado: (2018)

iADRs: towards online adverse drug reaction analysis
por: Lin, Wen-Yang, et al.
Publicado: (2012)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
por: WANG, LEI, et al.
Publicado: (2014)

Adverse Drug Reactions, Power, Harm Reduction, Regulation and the ADRe Profiles
por: Jordan, Sue, et al.
Publicado: (2018)

Gynecomastia: An ADR due to drug interaction
por: Aiman, Umme, et al.
Publicado: (2009)

ADR in Journals: Are They Translated into Regulatory Frameworks?
por: Kolupoti, Annapurna, et al.
Publicado: (2022)

Pharmacogenomics: a key component of personalized therapy
por: Schwab, Matthias, et al.
Publicado: (2012)

Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe
por: Huebner, Tatjana, et al.
Publicado: (2021)

Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe
por: Huebner, Tatjana, et al.
Publicado: (2021)

Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling
por: Huebner, Tatjana, et al.
Publicado: (2023)

Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
por: Klein, Kevin, et al.
Publicado: (2015)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

A Systematic Investigation of Computation Models for Predicting Adverse Drug Reactions (ADRs)
por: Kuang, Qifan, et al.
Publicado: (2014)

Analysis of Cutaneous Adverse Drug Reactions Reported at the Regional ADR Monitoring Center
por: Modi, Anal, et al.
Publicado: (2019)

Drug‐target‐ADR Network and Possible Implications of Structural Variants in Adverse Events
por: Dafniet, Bryan, et al.
Publicado: (2020)

Medical students as junior adverse drug event managers facilitating reporting of ADRs
por: Reumerman, Michael O., et al.
Publicado: (2021)

A SEVERE ADVERSE DRUG REACTION (ADR) TO REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)
por: Abou-Jaoude, E., et al.
Publicado: (2022)

Gene expression and proliferation biomarkers for antidepressant treatment resistance
por: Breitfeld, J, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nh2aqade0fastha2pna10a9qij